Unsal Kaya

Unsal Kaya has extensive experience in statistical programming and biostatistics, currently serving as Director of Statistical Programming at Cerevel Therapeutics since January 2021. Prior positions include Director of Statistical Programming at Cyclerion and roles at Ironwood Pharmaceuticals where positions included Associate Director and Manager of Statistical Programming. Unsal Kaya also has a strong background in SAS programming, with previous roles at Infinity Pharmaceuticals and CombinatoRx, as well as foundational experience as a SAS programmer at Millennium Pharmaceuticals and as a biostatistician at the Harvard Clinical Research Institute and Roswell Park Cancer Institute. Unsal Kaya holds a Master of Arts in Statistics from the University at Buffalo and a Bachelor's degree in Mathematics from Istanbul University.